Septerna is a biochemical drug discovery company. With GPCR scientists, Septerna is focused on researching G protein receptors to develop new medicines in the pharmacology field. The company also features drug-screening technology, modular assemblies, and Silico molecule screening. Septerna was founded by Arthur Christopoulos, Jeffrey Finer, Patrick Sexton, and Robert Lefkowitz in 2022 and is headquartered in San Francisco, CA.

Register for Details

For more details on financing and valuation for Septerna, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Septerna

Forge green plus iconForge green minus icon

What is Septerna's IPO price?

The IPO price for Septerna will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Septerna?

Septerna is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Septerna shares pre-IPO?

If you own Septerna pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Septerna a publicly traded company?

Septerna is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Septerna's funding to date?

Septerna has raised $225MM to date.
Forge green plus iconForge green minus icon

When was Septerna founded?

Septerna was founded in 2022.

Who are Septerna's major investors?

Casdin Capital
Goldman Sachs Asset Management
Ra Capital Management
Vertex Ventures
Mirae Asset Global Investments
Woodline Partners
Logos Capital
Samsara Biocapital
Soleus Capital
Third Rock Ventures
Deep Track Capital
Catalio Capital Management
Invus Financial Advisors
BVF Partners
Driehaus Capital

Septerna funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation

Series B

$150MM raised $XXX.XX $XXX.XX

Series A

$75MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jun 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.